© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Aims: The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopathy (HCM) is poorly studied. We sought to explore the relation between CVRF and the clinical characteristics of patients with HCM enrolled in the EURObservational Research Programme (EORP) Cardiomyopathy registry. Methods and results: 1739 patients with HCM were...
BACKGROUND: Severe left ventricular (LV) systolic dysfunction is an uncommon complication of hypertr...
Aims The Cardiomyopathy Registry of the EURObservational Research Programme is a prospective, observ...
Background: The term "end stage" has been used to describe hypertrophic cardiomyopathy (HCM) with le...
AIMS: The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopa...
The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopathy (H...
Hypertrophic cardiomyopathy (HCM) is a common, serious, genetic heart disorder. Rare pathogenic vari...
Copyright © 2022 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All righ...
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and is characterized b...
© 2018 Elsevier B.V. All rights reserved.Background: We present an ancillary study of the Portuguese...
Hypertrophic cardiomyopathy is a common autosomal dominant cardiovascular disease . Dynamic obstru...
Background: A better understanding of the factors that contribute to heterogeneous outcomes and life...
Hypertrophic cardiomyopathy (HCM) is a common, serious, genetic heart disorder. Rare pathogenic vari...
Aims: The European Society of Cardiology (ESC) European Observational Research Programme (EORP) Car...
AbstractHypertrophic cardiomyopathy (HCM) is an important genetic heart muscle disease for which pre...
The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes o...
BACKGROUND: Severe left ventricular (LV) systolic dysfunction is an uncommon complication of hypertr...
Aims The Cardiomyopathy Registry of the EURObservational Research Programme is a prospective, observ...
Background: The term "end stage" has been used to describe hypertrophic cardiomyopathy (HCM) with le...
AIMS: The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopa...
The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopathy (H...
Hypertrophic cardiomyopathy (HCM) is a common, serious, genetic heart disorder. Rare pathogenic vari...
Copyright © 2022 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All righ...
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and is characterized b...
© 2018 Elsevier B.V. All rights reserved.Background: We present an ancillary study of the Portuguese...
Hypertrophic cardiomyopathy is a common autosomal dominant cardiovascular disease . Dynamic obstru...
Background: A better understanding of the factors that contribute to heterogeneous outcomes and life...
Hypertrophic cardiomyopathy (HCM) is a common, serious, genetic heart disorder. Rare pathogenic vari...
Aims: The European Society of Cardiology (ESC) European Observational Research Programme (EORP) Car...
AbstractHypertrophic cardiomyopathy (HCM) is an important genetic heart muscle disease for which pre...
The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes o...
BACKGROUND: Severe left ventricular (LV) systolic dysfunction is an uncommon complication of hypertr...
Aims The Cardiomyopathy Registry of the EURObservational Research Programme is a prospective, observ...
Background: The term "end stage" has been used to describe hypertrophic cardiomyopathy (HCM) with le...